Vera Therapeutics (VERA) Net Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -180.95% |
| Dec 31, 2025 | 3,332.18% |
| Sep 30, 2025 | 244.95% |
| Jun 30, 2025 | 84.11% |
| Mar 31, 2025 | -157.43% |
| Dec 31, 2024 | 2,911.98% |
| Sep 30, 2024 | 104.93% |
| Jun 30, 2024 | -287.93% |
| Mar 31, 2024 | 28.42% |
| Dec 31, 2023 | 382.88% |
| Sep 30, 2023 | 93.79% |
| Jun 30, 2023 | -210.50% |
| Mar 31, 2023 | 623.40% |
| Dec 31, 2022 | 165.08% |
| Sep 30, 2022 | 67.33% |
| Jun 30, 2022 | -291.88% |
| Mar 31, 2022 | 588.45% |
| Dec 31, 2021 | -18.84% |
| Sep 30, 2021 | -113.02% |
| Jun 30, 2021 | 1,115.18% |
| Mar 31, 2021 | -107.91% |
| Dec 31, 2020 | 2,165.17% |
| Sep 30, 2020 | -20.66% |
| Jun 30, 2020 | -180.69% |